ARTICLE | Financial News
Transition Therapies sells IPO
February 28, 2001 8:00 AM UTC
Transition (CDNX:TTH), a developer of therapeutics for inflammatory and fibrotic diseases, raised C$5 million (US$3.3 million) in an IPO through the sale of 4 million shares at C$1.25. The deal was un...